Literature DB >> 19765677

Pathology analysis reveals that dysplastic pancreatic ductal lesions are frequent in patients with hereditary pancreatitis.

Vinciane Rebours1, Philippe Lévy, Jean-François Mosnier, Jean-Yves Scoazec, Marie-Sophie Soubeyrand, Jean-François Fléjou, Bruno Turlin, Pascal Hammel, Philippe Ruszniewski, Pierre Bedossa, Anne Couvelard.   

Abstract

BACKGROUND & AIMS: Hereditary pancreatitis (HP) is a risk factor for pancreatic adenocarcinoma. We performed a retrospective, multicenter study to characterize and evaluate the frequency of pancreatic intraepithelial neoplasia (PanIN) and to describe the characteristics of fibrosis in pancreatic surgical specimens from patients with HP.
METHODS: Samples from partial pancreatectomies (n = 13) of patients with HP complications (n = 12; 7 males; mean age, 24 y; 1 patient underwent 2 surgeries over 16 years) were analyzed by histologic and immunohistologic analyses; patients with suspected or proven pancreatic adenocarcinoma were excluded. HP diagnosis was confirmed by analysis of PRSS1 mutations. Dysplastic lesions were described according to the PanIN classification.
RESULTS: Eleven patients were found to have the R122H mutation in PRSS1 and 1 patient was found to have the N29I mutation in PRSS1. Fifty-one PanIN lesions were observed in 10 specimens (77%): PanIN lesions 1a, 1b, 2, and 3 were observed in 8, 5, 8, and 5 specimens, respectively. The median number of PanIN lesions was 3.5 for each specimen. The density of the lesions was 2.6 per 10 cm(2). The size of lesions was greater than 0.5 mm in 55% of the samples. Two patients with PanIN-3 developed pancreatic cancer, 18 months and 44 years after surgery.
CONCLUSIONS: PanIN lesions are frequent, severe, and occur early in the course of HP. Among patients with PanINs, 50% had PanIN-3 lesions. Pancreatectomy could be considered as a prophylactic against pancreatic cancer in patients with high-grade dysplasia. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765677     DOI: 10.1016/j.cgh.2009.09.009

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  11 in total

1.  The -409 C/T genotype of PRSS1 protects against pancreatic cancer in the Han Chinese population.

Authors:  Qicai Liu; Xinhua Lin; Jingfeng Liu; Ailin Liu; Feng Gao
Journal:  Dig Dis Sci       Date:  2011-09-16       Impact factor: 3.199

Review 2.  Pancreatic Cancer Screening.

Authors:  Koushik K Das; Dayna Early
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

Review 3.  Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer.

Authors:  Gabriele Lami; Maria Rosa Biagini; Andrea Galli
Journal:  World J Gastrointest Endosc       Date:  2014-07-16

4.  Hereditary pancreatitis for the endoscopist.

Authors:  Milan R Patel; Amanda L Eppolito; Field F Willingham
Journal:  Therap Adv Gastroenterol       Date:  2013-03       Impact factor: 4.409

5.  Hereditary Pancreatitis in the United States: Survival and Rates of Pancreatic Cancer.

Authors:  Celeste A Shelton; Chandraprakash Umapathy; Kimberly Stello; Dhiraj Yadav; David C Whitcomb
Journal:  Am J Gastroenterol       Date:  2018-07-18       Impact factor: 10.864

6.  Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report.

Authors:  Mark Steven Miller; Peter Allen; Teresa A Brentnall; Michael Goggins; Ralph H Hruban; Gloria M Petersen; Chinthalapally V Rao; David C Whitcomb; Randall E Brand; Suresh T Chari; Alison P Klein; David M Lubman; Andrew D Rhim; Diane M Simeone; Brian M Wolpin; Asad Umar; Sudhir Srivastava; Vernon E Steele; Jo Ann S Rinaudo
Journal:  Pancreas       Date:  2016-09       Impact factor: 3.327

7.  mAb Das-1 identifies pancreatic ductal adenocarcinoma and high-grade pancreatic intraepithelial neoplasia with high accuracy.

Authors:  Koushik K Das; Jeffrey W Brown; Carlos Fernandez Del-Castillo; Tiffany Huynh; Jason C Mills; Yoko Matsuda; Kiron M Das; Mari Mino-Kenudson
Journal:  Hum Pathol       Date:  2021-01-30       Impact factor: 3.466

Review 8.  The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.

Authors:  Elizabeth D Thompson; Nicholas J Roberts; Laura D Wood; James R Eshleman; Michael G Goggins; Scott E Kern; Alison P Klein; Ralph H Hruban
Journal:  Mod Pathol       Date:  2020-07-23       Impact factor: 7.842

9.  Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma.

Authors:  Shaiju K Vareed; Vadiraja B Bhat; Christopher Thompson; Vihas T Vasu; Damian Fermin; Hyungwon Choi; Chad J Creighton; Sitaram Gayatri; Ling Lan; Nagireddy Putluri; Gagan Singh Thangjam; Punit Kaur; Mohsen Shabahang; Judith G Giri; Alexey I Nesvizhskii; Alexander A A Asea; Anil G Cashikar; Arundhati Rao; James McLoughlin; Arun Sreekumar
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

Review 10.  Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer.

Authors:  Diane Lorenzo; Vinciane Rebours; Frédérique Maire; Maxime Palazzo; Jean-Michel Gonzalez; Marie-Pierre Vullierme; Alain Aubert; Pascal Hammel; Philippe Lévy; Louis de Mestier
Journal:  World J Gastroenterol       Date:  2019-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.